|
"peng cy"的相關文件
顯示項目 11-20 / 70 (共7頁)
<< < 1 2 3 4 5 6 7 > >>
每頁顯示[10|25|50]項目
| 中山醫學大學 |
2021 |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu, CH; Chen, PY; Chen, JJ; Lo, CC; Su, WW; Tseng, KC; Liu, CJ; Huang, CS; Huang, KJ; Yang, SS; Peng, CY; Tsai, MC; Kao, WY; Chang, CY; Shih, YL; Fang, YJ; Chen, CY; Lee, PL; Huang, JJ; Su, PY; Tseng, CW; Hung, CC; Chang, CH; Huang, YJ; Lai, HC; Chang, CC; Lee, FJ; Hsieh, TY; Kao, JH |
| 中山醫學大學 |
2021 |
Predictors of early progression after curative resection followed by platinum-based adjuvant chemoradiotherapy in oral cavity squamous cell carcinoma
|
Lu, HJ; Tseng, SW; Peng, CY; Tseng, HC; Hsin, CH; Chen, HL; Huang, WS; Wu, MF; Yang, MH; Chang, PMH |
| 中山醫學大學 |
2021 |
LncRNA MEG3 inhibits self-renewal and invasion abilities of oral cancer stem cells by sponging miR-421
|
Chen, PY; Hsieh, PL; Peng, CY; Liao, YW; Yu, CH; Yu, CC |
| 中山醫學大學 |
2021 |
Silencing periostin inhibits myofibroblast transdifferentiation of fibrotic buccal mucosal fibroblasts
|
Su, JY; Yu, CC; Peng, CY; Liao, YW; Hsieh, PL; Yang, LC; Yu, CH; Chou, MY |
| 中山醫學大學 |
2021 |
Clinical outcomes, prognosis, and predictors of salvage surgery in oral cavity squamous cell carcinoma.
|
Lan, WS; Lu, HJ; Chiu, YW; Peng, CY; Tseng, HC; Hsin, CH; Chuang, CY; Chen, CC; Huang, WS; Yang, SF |
| 中山醫學大學 |
2021 |
PEROXISOME-PROLIFERATOR ACTIVATOR RECEPTOR gamma IN MOUSE MODEL WITH MENINGOENCEPHALITIS CAUSED BY ANGIOSTRONGYLUS CANTONENSIS
|
Chen, KM; Peng, CY; Shyu, LY; Lan, KP; Lai, SC |
| 中山醫學大學 |
2021 |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu, CH; Chen, CY; Su, WW; Tseng, KC; Lo, CC; Liu, CJ; Chen, JJ; Peng, CY; Shih, YL; Yang, SS; Huang, CS; Huang, KJ; Chang, CY; Tsai, MC; Kao, WY; Fang, YJ; Chen, PY; Su, PY; Tseng, CW; Huang, JJ; Lee, PL; Lai, HC; Hsieh, TY; Chang, CH; Huang, YJ; Lee, FJ; Chang, CC; Kao, JH |
| 中山醫學大學 |
2021 |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng, PN; Mo, LR; Chen, CT; Chen, CY; Huang, CF; Kuo, HT; Lo, CC; Tseng, KC; Huang, YH; Tai, CM; Peng, CY; Bair, MJ; Chen, CH; Yeh, ML; Lin, CL; Lin, CY; Lee, PL; Chong, LW; Hung, CH; Chang, T; Huang, JF; Yang, CC; Hu, JT; Lin, CW; Wang, CC; Su, WW; Hsieh, TY; Lin, CL; Tsai, WL; Lee, TH; Chen, GY; Wang, SJ; Chang, CC; Yang, SS; Wu, WC; Huang, CS; Chou, KH; Kao, CN; Tsai, PC; Liu, CH; Lee, MH; Cheng, CY; Tsai, MC; Liu, CJ; Dai, CY; Lin, HC; Kao, JH; Chuang, WL; Yu, ML |
| 國家衛生研究院 |
2020-07-24 |
Next-Generation sequencing-based quantitative detection of hepatitis B virus Pre-S mutants in plasma predicts hepatocellular carcinoma recurrence
|
Teng, CF;Li, TC;Huang, HY;Lin, JH;Chen, WS;Shyu, WC;Wu, HC;Peng, CY;Su, IJ;Jeng, LB |
| 國家衛生研究院 |
2020-05 |
Simulating the spatiotemporal distribution of BTEX with an hourly grid-scale model
|
Hsieh, MT;Peng, CY;Chung, WY;Lai, CH;Huang, SK;Lee, CL |
顯示項目 11-20 / 70 (共7頁)
<< < 1 2 3 4 5 6 7 > >>
每頁顯示[10|25|50]項目
|
